ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global GalNAc-siRNA Conjugates Market Research Report 2024
Published Date: November 2024
|
Report Code: QYRE-Auto-31L18383
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global GalNAc siRNA Conjugates Market Research Report 2024
BUY CHAPTERS

Global GalNAc-siRNA Conjugates Market Research Report 2024

Code: QYRE-Auto-31L18383
Report
November 2024
Pages:97
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
WuXi XDC
BOCSCI Inc.
Creative Biogene
Creative-Biolabs
Bachem
Biosynthesis
LGC Biosearch Technologies
Sinopep
Organix
CD Formulation
HitGen LTD

GalNAc-siRNA Conjugates Market

GalNAc-siRNA conjugates are polysaccharide-siRNA monojugates formed by covalently affixing N-acetylated galactosamine (GalNAc) to the 3' end of the right-hand strand of siRNAs of different sequences in a trivalent state. GalNAc is a targeting ligand for the sialic acid receptor (ASGPR), which has a high affinity for liver surface cells and rapid internalization, thus enabling this class of siRNA conjugates to specifically bind membrane proteins into the cytosol. GalNAc conjugated modifications are currently the most commonly used small nucleic acid drug delivery system and have excellent potential for use in the treatment of liver-related diseases involving gene overexpression. GalNAc conjugates have largely replaced lipid nanoparticle (LNP) delivery for siRNA delivery in liver-targeted diseases.
The global GalNAc-siRNA Conjugates market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for GalNAc-siRNA Conjugates is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for GalNAc-siRNA Conjugates is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of GalNAc-siRNA Conjugates include WuXi XDC, BOCSCI Inc., Creative Biogene, Creative Biolabs, Bachem, Biosynthesis, LGC Biosearch Technologies, Sinopep, Organix, CD Formulation, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for GalNAc-siRNA Conjugates, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding GalNAc-siRNA Conjugates.
The GalNAc-siRNA Conjugates market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global GalNAc-siRNA Conjugates market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the GalNAc-siRNA Conjugates manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of GalNAc-siRNA Conjugates Market Report

Report Metric Details
Report Name GalNAc-siRNA Conjugates Market
by Type
  • Mono-GalNAc-siRNA
  • Di-GalNAc-siRNA
  • Tri-GalNAc-siRNA
  • Tetra-GalNAc-siRNA
by Application
Production by Region
  • North America
  • Europe
  • China
  • Japan
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company WuXi XDC, BOCSCI Inc., Creative Biogene, Creative Biolabs, Bachem, Biosynthesis, LGC Biosearch Technologies, Sinopep, Organix, CD Formulation, Hitgen
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of GalNAc-siRNA Conjugates manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of GalNAc-siRNA Conjugates in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the GalNAc-siRNA Conjugates Market report?

Ans: The main players in the GalNAc-siRNA Conjugates Market are WuXi XDC, BOCSCI Inc., Creative Biogene, Creative Biolabs, Bachem, Biosynthesis, LGC Biosearch Technologies, Sinopep, Organix, CD Formulation, Hitgen

What are the Application segmentation covered in the GalNAc-siRNA Conjugates Market report?

Ans: The Applications covered in the GalNAc-siRNA Conjugates Market report are Liver Disorders, Cancer, Neurodegenerative Conditions, Other

What are the Type segmentation covered in the GalNAc-siRNA Conjugates Market report?

Ans: The Types covered in the GalNAc-siRNA Conjugates Market report are Mono-GalNAc-siRNA, Di-GalNAc-siRNA, Tri-GalNAc-siRNA, Tetra-GalNAc-siRNA

Recommended Reports

Nucleic Acid Therapeutics

Oligonucleotide Conjugates

siRNA & RNA Delivery

1 GalNAc-siRNA Conjugates Market Overview
1.1 Product Definition
1.2 GalNAc-siRNA Conjugates by Type
1.2.1 Global GalNAc-siRNA Conjugates Market Value Comparison by Type (2024-2030)
1.2.2 Mono-GalNAc-siRNA
1.2.3 Di-GalNAc-siRNA
1.2.4 Tri-GalNAc-siRNA
1.2.5 Tetra-GalNAc-siRNA
1.3 GalNAc-siRNA Conjugates by Application
1.3.1 Global GalNAc-siRNA Conjugates Market Value by Application (2024-2030)
1.3.2 Liver Disorders
1.3.3 Cancer
1.3.4 Neurodegenerative Conditions
1.3.5 Other
1.4 Global GalNAc-siRNA Conjugates Market Size Estimates and Forecasts
1.4.1 Global GalNAc-siRNA Conjugates Revenue 2019-2030
1.4.2 Global GalNAc-siRNA Conjugates Sales 2019-2030
1.4.3 Global GalNAc-siRNA Conjugates Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 GalNAc-siRNA Conjugates Market Competition by Manufacturers
2.1 Global GalNAc-siRNA Conjugates Sales Market Share by Manufacturers (2019-2024)
2.2 Global GalNAc-siRNA Conjugates Revenue Market Share by Manufacturers (2019-2024)
2.3 Global GalNAc-siRNA Conjugates Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of GalNAc-siRNA Conjugates, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of GalNAc-siRNA Conjugates, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of GalNAc-siRNA Conjugates, Product Type & Application
2.7 Global Key Manufacturers of GalNAc-siRNA Conjugates, Date of Enter into This Industry
2.8 Global GalNAc-siRNA Conjugates Market Competitive Situation and Trends
2.8.1 Global GalNAc-siRNA Conjugates Market Concentration Rate
2.8.2 The Global 5 and 10 Largest GalNAc-siRNA Conjugates Players Market Share by Revenue
2.8.3 Global GalNAc-siRNA Conjugates Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global GalNAc-siRNA Conjugates Market Scenario by Region
3.1 Global GalNAc-siRNA Conjugates Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global GalNAc-siRNA Conjugates Sales by Region: 2019-2030
3.2.1 Global GalNAc-siRNA Conjugates Sales by Region: 2019-2024
3.2.2 Global GalNAc-siRNA Conjugates Sales by Region: 2025-2030
3.3 Global GalNAc-siRNA Conjugates Revenue by Region: 2019-2030
3.3.1 Global GalNAc-siRNA Conjugates Revenue by Region: 2019-2024
3.3.2 Global GalNAc-siRNA Conjugates Revenue by Region: 2025-2030
3.4 North America GalNAc-siRNA Conjugates Market Facts & Figures by Country
3.4.1 North America GalNAc-siRNA Conjugates Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America GalNAc-siRNA Conjugates Sales by Country (2019-2030)
3.4.3 North America GalNAc-siRNA Conjugates Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe GalNAc-siRNA Conjugates Market Facts & Figures by Country
3.5.1 Europe GalNAc-siRNA Conjugates Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe GalNAc-siRNA Conjugates Sales by Country (2019-2030)
3.5.3 Europe GalNAc-siRNA Conjugates Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific GalNAc-siRNA Conjugates Market Facts & Figures by Region
3.6.1 Asia Pacific GalNAc-siRNA Conjugates Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific GalNAc-siRNA Conjugates Sales by Region (2019-2030)
3.6.3 Asia Pacific GalNAc-siRNA Conjugates Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America GalNAc-siRNA Conjugates Market Facts & Figures by Country
3.7.1 Latin America GalNAc-siRNA Conjugates Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America GalNAc-siRNA Conjugates Sales by Country (2019-2030)
3.7.3 Latin America GalNAc-siRNA Conjugates Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa GalNAc-siRNA Conjugates Market Facts & Figures by Country
3.8.1 Middle East and Africa GalNAc-siRNA Conjugates Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa GalNAc-siRNA Conjugates Sales by Country (2019-2030)
3.8.3 Middle East and Africa GalNAc-siRNA Conjugates Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global GalNAc-siRNA Conjugates Sales by Type (2019-2030)
4.1.1 Global GalNAc-siRNA Conjugates Sales by Type (2019-2024)
4.1.2 Global GalNAc-siRNA Conjugates Sales by Type (2025-2030)
4.1.3 Global GalNAc-siRNA Conjugates Sales Market Share by Type (2019-2030)
4.2 Global GalNAc-siRNA Conjugates Revenue by Type (2019-2030)
4.2.1 Global GalNAc-siRNA Conjugates Revenue by Type (2019-2024)
4.2.2 Global GalNAc-siRNA Conjugates Revenue by Type (2025-2030)
4.2.3 Global GalNAc-siRNA Conjugates Revenue Market Share by Type (2019-2030)
4.3 Global GalNAc-siRNA Conjugates Price by Type (2019-2030)
5 Segment by Application
5.1 Global GalNAc-siRNA Conjugates Sales by Application (2019-2030)
5.1.1 Global GalNAc-siRNA Conjugates Sales by Application (2019-2024)
5.1.2 Global GalNAc-siRNA Conjugates Sales by Application (2025-2030)
5.1.3 Global GalNAc-siRNA Conjugates Sales Market Share by Application (2019-2030)
5.2 Global GalNAc-siRNA Conjugates Revenue by Application (2019-2030)
5.2.1 Global GalNAc-siRNA Conjugates Revenue by Application (2019-2024)
5.2.2 Global GalNAc-siRNA Conjugates Revenue by Application (2025-2030)
5.2.3 Global GalNAc-siRNA Conjugates Revenue Market Share by Application (2019-2030)
5.3 Global GalNAc-siRNA Conjugates Price by Application (2019-2030)
6 Key Companies Profiled
6.1 WuXi XDC
6.1.1 WuXi XDC Company Information
6.1.2 WuXi XDC Description and Business Overview
6.1.3 WuXi XDC GalNAc-siRNA Conjugates Sales, Revenue and Gross Margin (2019-2024)
6.1.4 WuXi XDC GalNAc-siRNA Conjugates Product Portfolio
6.1.5 WuXi XDC Recent Developments/Updates
6.2 BOCSCI Inc.
6.2.1 BOCSCI Inc. Company Information
6.2.2 BOCSCI Inc. Description and Business Overview
6.2.3 BOCSCI Inc. GalNAc-siRNA Conjugates Sales, Revenue and Gross Margin (2019-2024)
6.2.4 BOCSCI Inc. GalNAc-siRNA Conjugates Product Portfolio
6.2.5 BOCSCI Inc. Recent Developments/Updates
6.3 Creative Biogene
6.3.1 Creative Biogene Company Information
6.3.2 Creative Biogene Description and Business Overview
6.3.3 Creative Biogene GalNAc-siRNA Conjugates Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Creative Biogene GalNAc-siRNA Conjugates Product Portfolio
6.3.5 Creative Biogene Recent Developments/Updates
6.4 Creative Biolabs
6.4.1 Creative Biolabs Company Information
6.4.2 Creative Biolabs Description and Business Overview
6.4.3 Creative Biolabs GalNAc-siRNA Conjugates Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Creative Biolabs GalNAc-siRNA Conjugates Product Portfolio
6.4.5 Creative Biolabs Recent Developments/Updates
6.5 Bachem
6.5.1 Bachem Company Information
6.5.2 Bachem Description and Business Overview
6.5.3 Bachem GalNAc-siRNA Conjugates Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Bachem GalNAc-siRNA Conjugates Product Portfolio
6.5.5 Bachem Recent Developments/Updates
6.6 Biosynthesis
6.6.1 Biosynthesis Company Information
6.6.2 Biosynthesis Description and Business Overview
6.6.3 Biosynthesis GalNAc-siRNA Conjugates Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Biosynthesis GalNAc-siRNA Conjugates Product Portfolio
6.6.5 Biosynthesis Recent Developments/Updates
6.7 LGC Biosearch Technologies
6.7.1 LGC Biosearch Technologies Company Information
6.7.2 LGC Biosearch Technologies Description and Business Overview
6.7.3 LGC Biosearch Technologies GalNAc-siRNA Conjugates Sales, Revenue and Gross Margin (2019-2024)
6.7.4 LGC Biosearch Technologies GalNAc-siRNA Conjugates Product Portfolio
6.7.5 LGC Biosearch Technologies Recent Developments/Updates
6.8 Sinopep
6.8.1 Sinopep Company Information
6.8.2 Sinopep Description and Business Overview
6.8.3 Sinopep GalNAc-siRNA Conjugates Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Sinopep GalNAc-siRNA Conjugates Product Portfolio
6.8.5 Sinopep Recent Developments/Updates
6.9 Organix
6.9.1 Organix Company Information
6.9.2 Organix Description and Business Overview
6.9.3 Organix GalNAc-siRNA Conjugates Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Organix GalNAc-siRNA Conjugates Product Portfolio
6.9.5 Organix Recent Developments/Updates
6.10 CD Formulation
6.10.1 CD Formulation Company Information
6.10.2 CD Formulation Description and Business Overview
6.10.3 CD Formulation GalNAc-siRNA Conjugates Sales, Revenue and Gross Margin (2019-2024)
6.10.4 CD Formulation GalNAc-siRNA Conjugates Product Portfolio
6.10.5 CD Formulation Recent Developments/Updates
6.11 Hitgen
6.11.1 Hitgen Company Information
6.11.2 Hitgen Description and Business Overview
6.11.3 Hitgen GalNAc-siRNA Conjugates Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Hitgen GalNAc-siRNA Conjugates Product Portfolio
6.11.5 Hitgen Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 GalNAc-siRNA Conjugates Industry Chain Analysis
7.2 GalNAc-siRNA Conjugates Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 GalNAc-siRNA Conjugates Production Mode & Process
7.4 GalNAc-siRNA Conjugates Sales and Marketing
7.4.1 GalNAc-siRNA Conjugates Sales Channels
7.4.2 GalNAc-siRNA Conjugates Distributors
7.5 GalNAc-siRNA Conjugates Customers
8 GalNAc-siRNA Conjugates Market Dynamics
8.1 GalNAc-siRNA Conjugates Industry Trends
8.2 GalNAc-siRNA Conjugates Market Drivers
8.3 GalNAc-siRNA Conjugates Market Challenges
8.4 GalNAc-siRNA Conjugates Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
WuXi XDC
BOCSCI Inc.
Creative Biogene
Creative-Biolabs
Bachem
Biosynthesis
LGC Biosearch Technologies
Sinopep
Organix
CD Formulation
HitGen LTD
List of Tables
 Table 1. Global GalNAc-siRNA Conjugates Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global GalNAc-siRNA Conjugates Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global GalNAc-siRNA Conjugates Market Competitive Situation by Manufacturers in 2023
 Table 4. Global GalNAc-siRNA Conjugates Sales (Kg) of Key Manufacturers (2019-2024)
 Table 5. Global GalNAc-siRNA Conjugates Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global GalNAc-siRNA Conjugates Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global GalNAc-siRNA Conjugates Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market GalNAc-siRNA Conjugates Average Price (US$/g) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of GalNAc-siRNA Conjugates, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of GalNAc-siRNA Conjugates, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of GalNAc-siRNA Conjugates, Product Type & Application
 Table 12. Global Key Manufacturers of GalNAc-siRNA Conjugates, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global GalNAc-siRNA Conjugates by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in GalNAc-siRNA Conjugates as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global GalNAc-siRNA Conjugates Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global GalNAc-siRNA Conjugates Sales by Region (2019-2024) & (Kg)
 Table 18. Global GalNAc-siRNA Conjugates Sales Market Share by Region (2019-2024)
 Table 19. Global GalNAc-siRNA Conjugates Sales by Region (2025-2030) & (Kg)
 Table 20. Global GalNAc-siRNA Conjugates Sales Market Share by Region (2025-2030)
 Table 21. Global GalNAc-siRNA Conjugates Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global GalNAc-siRNA Conjugates Revenue Market Share by Region (2019-2024)
 Table 23. Global GalNAc-siRNA Conjugates Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global GalNAc-siRNA Conjugates Revenue Market Share by Region (2025-2030)
 Table 25. North America GalNAc-siRNA Conjugates Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America GalNAc-siRNA Conjugates Sales by Country (2019-2024) & (Kg)
 Table 27. North America GalNAc-siRNA Conjugates Sales by Country (2025-2030) & (Kg)
 Table 28. North America GalNAc-siRNA Conjugates Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America GalNAc-siRNA Conjugates Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe GalNAc-siRNA Conjugates Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe GalNAc-siRNA Conjugates Sales by Country (2019-2024) & (Kg)
 Table 32. Europe GalNAc-siRNA Conjugates Sales by Country (2025-2030) & (Kg)
 Table 33. Europe GalNAc-siRNA Conjugates Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe GalNAc-siRNA Conjugates Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific GalNAc-siRNA Conjugates Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific GalNAc-siRNA Conjugates Sales by Region (2019-2024) & (Kg)
 Table 37. Asia Pacific GalNAc-siRNA Conjugates Sales by Region (2025-2030) & (Kg)
 Table 38. Asia Pacific GalNAc-siRNA Conjugates Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific GalNAc-siRNA Conjugates Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America GalNAc-siRNA Conjugates Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America GalNAc-siRNA Conjugates Sales by Country (2019-2024) & (Kg)
 Table 42. Latin America GalNAc-siRNA Conjugates Sales by Country (2025-2030) & (Kg)
 Table 43. Latin America GalNAc-siRNA Conjugates Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America GalNAc-siRNA Conjugates Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa GalNAc-siRNA Conjugates Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa GalNAc-siRNA Conjugates Sales by Country (2019-2024) & (Kg)
 Table 47. Middle East and Africa GalNAc-siRNA Conjugates Sales by Country (2025-2030) & (Kg)
 Table 48. Middle East and Africa GalNAc-siRNA Conjugates Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa GalNAc-siRNA Conjugates Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global GalNAc-siRNA Conjugates Sales (Kg) by Type (2019-2024)
 Table 51. Global GalNAc-siRNA Conjugates Sales (Kg) by Type (2025-2030)
 Table 52. Global GalNAc-siRNA Conjugates Sales Market Share by Type (2019-2024)
 Table 53. Global GalNAc-siRNA Conjugates Sales Market Share by Type (2025-2030)
 Table 54. Global GalNAc-siRNA Conjugates Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global GalNAc-siRNA Conjugates Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global GalNAc-siRNA Conjugates Revenue Market Share by Type (2019-2024)
 Table 57. Global GalNAc-siRNA Conjugates Revenue Market Share by Type (2025-2030)
 Table 58. Global GalNAc-siRNA Conjugates Price (US$/g) by Type (2019-2024)
 Table 59. Global GalNAc-siRNA Conjugates Price (US$/g) by Type (2025-2030)
 Table 60. Global GalNAc-siRNA Conjugates Sales (Kg) by Application (2019-2024)
 Table 61. Global GalNAc-siRNA Conjugates Sales (Kg) by Application (2025-2030)
 Table 62. Global GalNAc-siRNA Conjugates Sales Market Share by Application (2019-2024)
 Table 63. Global GalNAc-siRNA Conjugates Sales Market Share by Application (2025-2030)
 Table 64. Global GalNAc-siRNA Conjugates Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global GalNAc-siRNA Conjugates Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global GalNAc-siRNA Conjugates Revenue Market Share by Application (2019-2024)
 Table 67. Global GalNAc-siRNA Conjugates Revenue Market Share by Application (2025-2030)
 Table 68. Global GalNAc-siRNA Conjugates Price (US$/g) by Application (2019-2024)
 Table 69. Global GalNAc-siRNA Conjugates Price (US$/g) by Application (2025-2030)
 Table 70. WuXi XDC Company Information
 Table 71. WuXi XDC Description and Business Overview
 Table 72. WuXi XDC GalNAc-siRNA Conjugates Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 73. WuXi XDC GalNAc-siRNA Conjugates Product
 Table 74. WuXi XDC Recent Developments/Updates
 Table 75. BOCSCI Inc. Company Information
 Table 76. BOCSCI Inc. Description and Business Overview
 Table 77. BOCSCI Inc. GalNAc-siRNA Conjugates Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 78. BOCSCI Inc. GalNAc-siRNA Conjugates Product
 Table 79. BOCSCI Inc. Recent Developments/Updates
 Table 80. Creative Biogene Company Information
 Table 81. Creative Biogene Description and Business Overview
 Table 82. Creative Biogene GalNAc-siRNA Conjugates Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 83. Creative Biogene GalNAc-siRNA Conjugates Product
 Table 84. Creative Biogene Recent Developments/Updates
 Table 85. Creative Biolabs Company Information
 Table 86. Creative Biolabs Description and Business Overview
 Table 87. Creative Biolabs GalNAc-siRNA Conjugates Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 88. Creative Biolabs GalNAc-siRNA Conjugates Product
 Table 89. Creative Biolabs Recent Developments/Updates
 Table 90. Bachem Company Information
 Table 91. Bachem Description and Business Overview
 Table 92. Bachem GalNAc-siRNA Conjugates Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 93. Bachem GalNAc-siRNA Conjugates Product
 Table 94. Bachem Recent Developments/Updates
 Table 95. Biosynthesis Company Information
 Table 96. Biosynthesis Description and Business Overview
 Table 97. Biosynthesis GalNAc-siRNA Conjugates Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 98. Biosynthesis GalNAc-siRNA Conjugates Product
 Table 99. Biosynthesis Recent Developments/Updates
 Table 100. LGC Biosearch Technologies Company Information
 Table 101. LGC Biosearch Technologies Description and Business Overview
 Table 102. LGC Biosearch Technologies GalNAc-siRNA Conjugates Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 103. LGC Biosearch Technologies GalNAc-siRNA Conjugates Product
 Table 104. LGC Biosearch Technologies Recent Developments/Updates
 Table 105. Sinopep Company Information
 Table 106. Sinopep Description and Business Overview
 Table 107. Sinopep GalNAc-siRNA Conjugates Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 108. Sinopep GalNAc-siRNA Conjugates Product
 Table 109. Sinopep Recent Developments/Updates
 Table 110. Organix Company Information
 Table 111. Organix Description and Business Overview
 Table 112. Organix GalNAc-siRNA Conjugates Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 113. Organix GalNAc-siRNA Conjugates Product
 Table 114. Organix Recent Developments/Updates
 Table 115. CD Formulation Company Information
 Table 116. CD Formulation Description and Business Overview
 Table 117. CD Formulation GalNAc-siRNA Conjugates Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 118. CD Formulation GalNAc-siRNA Conjugates Product
 Table 119. CD Formulation Recent Developments/Updates
 Table 120. Hitgen Company Information
 Table 121. Hitgen Description and Business Overview
 Table 122. Hitgen GalNAc-siRNA Conjugates Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 123. Hitgen GalNAc-siRNA Conjugates Product
 Table 124. Hitgen Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. GalNAc-siRNA Conjugates Distributors List
 Table 128. GalNAc-siRNA Conjugates Customers List
 Table 129. GalNAc-siRNA Conjugates Market Trends
 Table 130. GalNAc-siRNA Conjugates Market Drivers
 Table 131. GalNAc-siRNA Conjugates Market Challenges
 Table 132. GalNAc-siRNA Conjugates Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of GalNAc-siRNA Conjugates
 Figure 2. Global GalNAc-siRNA Conjugates Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global GalNAc-siRNA Conjugates Market Share by Type: 2023 & 2030
 Figure 4. Mono-GalNAc-siRNA Product Picture
 Figure 5. Di-GalNAc-siRNA Product Picture
 Figure 6. Tri-GalNAc-siRNA Product Picture
 Figure 7. Tetra-GalNAc-siRNA Product Picture
 Figure 8. Global GalNAc-siRNA Conjugates Market Value by Application (2024-2030) & (US$ Million)
 Figure 9. Global GalNAc-siRNA Conjugates Market Share by Application: 2023 & 2030
 Figure 10. Liver Disorders
 Figure 11. Cancer
 Figure 12. Neurodegenerative Conditions
 Figure 13. Other
 Figure 14. Global GalNAc-siRNA Conjugates Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 15. Global GalNAc-siRNA Conjugates Market Size (2019-2030) & (US$ Million)
 Figure 16. Global GalNAc-siRNA Conjugates Sales (2019-2030) & (Kg)
 Figure 17. Global GalNAc-siRNA Conjugates Average Price (US$/g) & (2019-2030)
 Figure 18. GalNAc-siRNA Conjugates Report Years Considered
 Figure 19. GalNAc-siRNA Conjugates Sales Share by Manufacturers in 2023
 Figure 20. Global GalNAc-siRNA Conjugates Revenue Share by Manufacturers in 2023
 Figure 21. Global 5 and 10 Largest GalNAc-siRNA Conjugates Players: Market Share by Revenue in GalNAc-siRNA Conjugates in 2023
 Figure 22. GalNAc-siRNA Conjugates Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 23. Global GalNAc-siRNA Conjugates Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 24. North America GalNAc-siRNA Conjugates Sales Market Share by Country (2019-2030)
 Figure 25. North America GalNAc-siRNA Conjugates Revenue Market Share by Country (2019-2030)
 Figure 26. United States GalNAc-siRNA Conjugates Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 27. Canada GalNAc-siRNA Conjugates Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 28. Europe GalNAc-siRNA Conjugates Sales Market Share by Country (2019-2030)
 Figure 29. Europe GalNAc-siRNA Conjugates Revenue Market Share by Country (2019-2030)
 Figure 30. Germany GalNAc-siRNA Conjugates Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. France GalNAc-siRNA Conjugates Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. U.K. GalNAc-siRNA Conjugates Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 33. Italy GalNAc-siRNA Conjugates Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 34. Russia GalNAc-siRNA Conjugates Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 35. Asia Pacific GalNAc-siRNA Conjugates Sales Market Share by Region (2019-2030)
 Figure 36. Asia Pacific GalNAc-siRNA Conjugates Revenue Market Share by Region (2019-2030)
 Figure 37. China GalNAc-siRNA Conjugates Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. Japan GalNAc-siRNA Conjugates Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. South Korea GalNAc-siRNA Conjugates Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. India GalNAc-siRNA Conjugates Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Australia GalNAc-siRNA Conjugates Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. China Taiwan GalNAc-siRNA Conjugates Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. Southeast Asia GalNAc-siRNA Conjugates Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Latin America GalNAc-siRNA Conjugates Sales Market Share by Country (2019-2030)
 Figure 45. Mexico GalNAc-siRNA Conjugates Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Brazil GalNAc-siRNA Conjugates Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 47. Argentina GalNAc-siRNA Conjugates Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 48. Colombia GalNAc-siRNA Conjugates Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 49. Middle East and Africa GalNAc-siRNA Conjugates Sales Market Share by Country (2019-2030)
 Figure 50. Middle East and Africa GalNAc-siRNA Conjugates Revenue Market Share by Country (2019-2030)
 Figure 51. Turkey GalNAc-siRNA Conjugates Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 52. Saudi Arabia GalNAc-siRNA Conjugates Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 53. UAE GalNAc-siRNA Conjugates Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 54. Global Sales Market Share of GalNAc-siRNA Conjugates by Type (2019-2030)
 Figure 55. Global Revenue Market Share of GalNAc-siRNA Conjugates by Type (2019-2030)
 Figure 56. Global GalNAc-siRNA Conjugates Price (US$/g) by Type (2019-2030)
 Figure 57. Global Sales Market Share of GalNAc-siRNA Conjugates by Application (2019-2030)
 Figure 58. Global Revenue Market Share of GalNAc-siRNA Conjugates by Application (2019-2030)
 Figure 59. Global GalNAc-siRNA Conjugates Price (US$/g) by Application (2019-2030)
 Figure 60. GalNAc-siRNA Conjugates Value Chain
 Figure 61. GalNAc-siRNA Conjugates Production Process
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Global GalNAc siRNA Conjugates Drug Market Research Report 2024
Global GalNAc Oligonucleotide Conjugates Market Research Report 2024
Global GalNAc Delivery Technology Market Research Report 2024
Global GalNAc ASO Conjugates Market Research Report 2024
Global GalNAc based Drug Market Research Report 2024
Global GalNAc and GalNAc Derivatives Market Research Report 2024
Global GalNac Conjugates Market Research Report 2024
Global siRNA Conjugates Market Research Report 2024
Global mRNA Delivery System Market Research Report 2024
Global Small Interfering RNA siRNA Therapeutics Market Insights Forecast to 2030
Global Oligonucleotide Bioconjugation Service Market Research Report 2024
Global Peptide PNA Peptide nucleic acid Conjugate Market Research Report 2024
Global PNA Conjugates Market Research Report 2024
Nucleic Acid Delivery Excipients Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Oligonucleotide Conjugates Market Research Report 2024
Global Antibody siRNA Conjugates Market Research Report 2024
Global RNA Interference RNAi Based Therapeutics Market Research Report 2024
Global Antibody oligonucleotide Conjugates AOCs Market Research Report 2024
Global LNP Synthesis System Market Research Report 2024
Global Lipid Nanoparticles LNP Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions